jueves, 6 de octubre de 2022

The immune responses and safety of fractional third-doses of heterologous COVID-19 vaccines after CoronaVac primary series

The immune responses and safety of fractional third-doses of heterologous COVID-19 vaccines after CoronaVac primary series

No hay comentarios:

Publicar un comentario